Neuropeptides
Volume 44, Issue 1 , Pages 9-16 , February 2010

Ethanol exposure selectively alters β-endorphin content but not [3H]-DAMGO binding in discrete regions of the rat brain

Received 16 July 2009 ,Accepted 25 November 2009.

References 

  1. Anton RF, Oroszi G, O’Malley S, Couper D, Swift R, Pettinati H, et al. An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the combined pharmacotherapies and behavioral interventions for alcohol dependence (COMBINE) study. Arch. Gen. Psychiatry. 2008;65:135–144
  2. Anwer J, Soliman MR. Ethanol-induced alterations in beta-endorphin levels in specific rat brain regions: modulation by adenosine agonist and antagonist. Pharmacology. 1995;51:364–369
  3. Blum K, Briggs AH, DeLallo L, Elston SF, Ochoa R. Whole brain methionine–enkephalin of ethanol-avoiding and ethanol-preferring c57BL mice. Experientia. 1982;38:1469–1470
  4. Boyadjieva N, Dokur M, Advis JP, Meadows GG, Sarkar DK. Chronic ethanol inhibits NK cell cytolytic activity: role of opioid peptide beta-endorphin. J. Immunol. 2001;167:5645–5652
  5. Cichelli MJ, Lewis MJ. Naloxone nonselective suppression of drinking of ethanol, sucrose, saccharin, and water by rats. Pharmacol. Biochem. Behav. 2002;72:699–706
  6. Cowen MS, Lawrence AJ. The role of opioid–dopamine interactions in the induction and maintenance of ethanol consumption. Prog. Neuropsychopharmacol. Biol. Psychiatry. 1999;23:1171–1212
  7. Davidson D, Amit Z. Naltrexone blocks acquisition of voluntary ethanol intake in rats. Alcohol. Clin. Exp. Res. 1997;21:677–683
  8. De Waele JP, Papachristou DN, Gianoulakis C. The alcohol-preferring C57BL/6 mice present an enhanced sensitivity of the hypothalamic beta-endorphin system to ethanol than the alcohol-avoiding DBA/2 mice. J. Pharmacol. Exp. Ther. 1992;261:788–794
  9. Deby-Dupont G, Reuter AM, Joris J, Vrindts-Gevaert Y, Franchimont P. Labeling of beta-endorphin and beta-lipotropin with iodine 125. C. R. Seances Soc. Biol. Fil. 1983;177:259–268
  10. Fadda P, Tronci S, Colombo G, Fratta W. Differences in the opioid system in selected brain regions of alcohol-preferring and alcohol-nonpreferring rats. Alcohol. Clin. Exp. Res. 1999;23:1296–1305
  11. Gianoulakis C. Characterization of the effects of acute ethanol administration on the release of beta-endorphin peptides by the rat hypothalamus. Eur. J. Pharmacol. 1990;180:21–29
  12. Gianoulakis C, Gupta A. Inbred strains of mice with variable sensitivity to ethanol exhibit differences in the content and processing of beta-endorphin. Life Sci. 1986;39:2315–2325
  13. Gianoulakis C, Beliveau D, Angelogianni P, Meaney M, Thavundayil J, Tawar V, et al. Different pituitary beta-endorphin and adrenal cortisol response to ethanol in individuals with high and low risk for future development of alcoholism. Life Sci. 1989;45:1097–1109
  14. Gianoulakis C, De Waele JP, Kiianmaa K. Differences in the brain and pituitary beta-endorphin system between the alcohol-preferring AA and alcohol-avoiding ANA rats. Alcohol. Clin. Exp. Res. 1992;16:453–459
  15. Grisel JE, Mogil JS, Grahame NJ, Rubinstein M, Belknap JK, Crabbe JC, et al. Ethanol oral self-administration is increased in mutant mice with decreased beta-endorphin expression. Brain Res. 1999;835:62–67
  16. Guitart-Masip M, Gimenez-Llort L, Fernandez-Teruel A, Canete T, Tobena A, Ogren SO, et al. Reduced ethanol response in the alcohol-preferring RHA rats and neuropeptide mRNAs in relevant structures. Eur. J. Neurosci. 2006;23:531–540
  17. Herz A. Endogenous opioid systems and alcohol addiction. Psychopharmacology (Berl). 1997;129:99–111
  18. Hyytiä P, Kiianmaa K. Suppression of ethanol responding by centrally administered CTOP and naltrindole in AA and Wistar rats. Alcohol. Clin. Exp. Res. 2001;25:25–33
  19. Jamensky NT, Gianoulakis C. Comparison of the proopiomelanocortin and proenkephalin opioid peptide systems in brain regions of the alcohol-preferring C57BL/6 and alcohol-avoiding DBA/2 mice. Alcohol. 1999;18:177–187
  20. Kelley AE, Bakshi VP, Haber SN, Steininger TL, Will MJ, Zhang M. Opioid modulation of taste hedonics within the ventral striatum. Physiol. Behav. 2002;76:365–377
  21. Kelley AE, Will MJ, Steininger TL, Zhang M, Haber SN. Restricted daily consumption of a highly palatable food (chocolate Ensure(R)) alters striatal enkephalin gene expression. Eur. J. Neurosci. 2003;18:2592–2598
  22. Kerdelhue B, Karteszi M, Pasqualini C, Reinberg A, Mezey E, Palkovits M. Circadian variations in beta-endorphin concentrations in pituitary and in some brain nuclei of the adult male rat. Brain Res. 1983;261:243–248
  23. Lam MP, Marinelli PW, Bai L, Gianoulakis C. Effects of acute ethanol on opioid peptide release in the central amygdala: an in vivo microdialysis study. Psychopharmacology (Berl). 2008;201:261–271
  24. Leriche M, Cote-Velez A, Méndez M. Presence of pro-opiomelanocortin mRNA in the rat medial prefrontal cortex, nucleus accumbens and ventral tegmental area: studies by RT-PCR and in situ hybridization techniques. Neuropeptides. 2007;41:421–431
  25. Li XW, Li TK, Froehlich JC. Enhanced sensitivity of the nucleus accumbens proenkephalin system to alcohol in rats selectively bred for alcohol preference. Brain Res. 1998;794:35–47
  26. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951;193:265–275
  27. Mansour A, Khachaturian H, Lewis ME, Akil H, Watson SJ. Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. J. Neurosci. 1987;7:2445–2464
  28. Marinelli PW, Quirion R, Gianoulakis C. A microdialysis profile of beta-endorphin and catecholamines in the rat nucleus accumbens following alcohol administration. Psychopharmacology (Berl). 2003;169:60–67
  29. Méndez M, Leriche M, Calva JC. Acute ethanol administration differentially modulates mu opioid receptors in the rat meso-accumbens and mesocortical pathways. Brain Res. Mol. Brain Res. 2001;94:148–156
  30. Méndez M, Morales-Mulia M. Role of mu and delta opioid receptors in alcohol drinking behaviour. Curr. Drug Abuse Rev. 2008;2:239–252
  31. Méndez M, Morales-Mulia M, Pérez-Luna JM. Ethanol-induced changes in proenkephalin mRNA expression in the rat nigrostriatal pathway. J. Mol. Neurosci. 2008;34:225–234
  32. Ng GY, O’Dowd BF, George SR. Genotypic differences in mesolimbic enkephalin gene expression in DBA/2J and C57BL/6J inbred mice. Eur. J. Pharmacol. 1996;311:45–52
  33. Olive MF, Koenig HN, Nannini MA, Hodge CW. Stimulation of endorphin neurotransmission in the nucleus accumbens by ethanol, cocaine, and amphetamine. J. Neurosci. 2001;21:RC184
  34. O’Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Arch. Gen. Psychiatry. 1992;49:881–887
  35. Patel VA, Pohorecky LA. Acute and chronic ethanol treatment on beta-endorphin and catecholamine levels. Alcohol. 1989;6:59–63
  36. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. forth ed.. San Diego: Academic Press; 1998;
  37. Phillips TJ, Wenger CD, Dorow JD. Naltrexone effects on ethanol drinking acquisition and on established ethanol consumption in C57BL/6J mice. Alcohol. Clin. Exp. Res. 1997;21:691–702
  38. Poplawski MM, Boyadjieva N, Sarkar DK. Vasoactive intestinal peptide and corticotropin-releasing hormone increase beta-endorphin release and proopiomelanocortin messenger RNA levels in primary cultures of hypothalamic cells: effects of acute and chronic ethanol treatment. Alcohol. Clin. Exp. Res. 2005;29:648–655
  39. Popp RL, Erickson CK. The effect of an acute ethanol exposure on the rat brain POMC opiopeptide system. Alcohol. 1998;16:139–148
  40. Przewlocka B, Dziedzicka M, Lason W. The effects of ethanol treatment on endogenous opioid peptides level and analgesia in monoarthritic rats. Pol. J. Pharmacol. Pharm. 1990;42:343–349
  41. Rasmussen DD, Bryant CA, Boldt BM, Colasurdo EA, Levin N, Wilkinson CW. Acute alcohol effects on opiomelanocortinergic regulation. Alcohol. Clin. Exp. Res. 1998;22:789–801
  42. Rees LH, Cook DM, Kendall JW, Allen CF, Kramer RM, Ratcliffe JG, et al. A radioimmunoassay for rat plasma ACTH. Endocrinology. 1971;89:254–261
  43. Richardson HN, Lee SY, O’Dell LE, Koob GF, Rivier CL. Alcohol self-administration acutely stimulates the hypothalamic-pituitary–adrenal axis, but alcohol dependence leads to a dampened neuroendocrine state. Eur. J. Neurosci. 2008;28:1641–1653
  44. Roberts AJ, McDonald JS, Heyser CJ, Kieffer BL, Matthes HW, Koob GF, et al. Mu-opioid receptor knockout mice do not self-administer alcohol. J. Pharmacol. Exp. Ther. 2000;293:1002–1008
  45. Robinson DL, Carelli RM. Distinct subsets of nucleus accumbens neurons encode operant responding for ethanol versus water. Eur. J. Neurosci. 2008;28:1887–1894
  46. Saland LC, Abeyta A, Frausto S, Raymond-Stintz M, Hastings CM, Carta M, et al. Chronic ethanol consumption reduces delta-and mu-opioid receptor-stimulated G-protein coupling in rat brain. Alcohol. Clin. Exp. Res. 2004;28:98–104
  47. Schulz R, Wuster M, Duka T, Herz A. Acute and chronic ethanol treatment changes endorphin levels in brain and pituitary. Psychopharmacology (Berl). 1980;68:221–227
  48. Seizinger BR, Bovermann K, Maysinger D, Hollt V, Herz A. Differential effects of acute and chronic ethanol treatment on particular opioid peptide systems in discrete regions of rat brain and pituitary. Pharmacol. Biochem. Behav. 1983;18(Suppl. 1):361–369
  49. Seizinger BR, Bovermann K, Hollt V, Herz A. Enhanced activity of the beta-endorphinergic system in the anterior and neurointermediate lobe of the rat pituitary after chronic treatment with ethanol liquid diet. J. Pharmacol. Exp. Ther. 1984;230:455–461
  50. Shoaib M, Spanagel R, Stohr T, Shippenberg TS. Strain differences in the rewarding and dopamine-releasing effects of morphine in rats. Psychopharmacology (Berl). 1995;117:240–247
  51. Sim-Selley LJ, Sharpe AL, Vogt LJ, Brunk LK, Selley DE, Samson HH. Effect of ethanol self-administration on mu- and delta-opioid receptor-mediated G-protein activity. Alcohol. Clin. Exp. Res. 2002;26:688–694
  52. Spanagel R, Herz A, Shippenberg TS. Identification of the opioid receptor types mediating beta-endorphin-induced alterations in dopamine release in the nucleus accumbens. Eur. J. Pharmacol. 1990;190:177–184
  53. Spanagel R, Herz A, Shippenberg TS. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc. Natl. Acad. Sci. USA. 1992;89:2046–2050
  54. Stromberg MF, Casale M, Volpicelli L, Volpicelli JR, O’Brien CP. A comparison of the effects of the opioid antagonists naltrexone, naltrindole, and beta-funaltrexamine on ethanol consumption in the rat. Alcohol. 1998;15:281–289
  55. Tempel A, Zukin RS. Neuroanatomical patterns of the mu, delta, and kappa opioid receptors of rat brain as determined by quantitative in vitro autoradiography. Proc. Natl. Acad. Sci. USA. 1987;84:4308–4312
  56. Turchan J, Przewlocka B, Toth G, Lason W, Borsodi A, Przewlocki R. The effect of repeated administration of morphine, cocaine and ethanol on mu and delta opioid receptor density in the nucleus accumbens and striatum of the rat. Neuroscience. 1999;91:971–977
  57. Vengeliene V, Bilbao A, Molander A, Spanagel R. Neuropharmacology of alcohol addiction. Br. J. Pharmacol. 2008;154:299–315
  58. Verhoef J, Wiegant VM, De Wied D. Regional distribution of alpha- and gamma-type endorphins in rat brain. Brain Res. 1982;231:454–460
  59. Vescovi PP, Coiro V, Volpi R, Giannini A, Passeri M. Plasma beta-endorphin, but not met-enkephalin levels are abnormal in chronic alcoholics. Alcohol Alcohol. 1992;27:471–475
  60. Volpicelli JR, Alterman AI, Hayashida M, O’Brien CP. Naltrexone in the treatment of alcohol dependence. Arch. Gen. Psychiatry. 1992;49:876–880
  61. Welch CC, Kim EM, Grace MK, Billington CJ, Levine AS. Palatability-induced hyperphagia increases hypothalamic dynorphin peptide and mRNA levels. Brain Res. 1996;721:126–131
  62. Wheeler RA, Carelli RM. Dissecting motivational circuitry to understand substance abuse. Neuropharmacology. 2009;56(Suppl.):149–159
  63. Zalewska-Kaszubska J, Czarnecka E. Deficit in beta-endorphin peptide and tendency to alcohol abuse. Peptides. 2005;26:701–705

PII: S0143-4179(09)00138-3

doi: 10.1016/j.npep.2009.11.009

Neuropeptides
Volume 44, Issue 1 , Pages 9-16 , February 2010

Article Tools

* Image Usage & Resolution